synopsisdenovodesign.be

What It Is

Synopsis is a design platform for molecular de novo design, maintained and distributed by Frits Daeyaert. According to the website, its main distinction from existing molecular design algorithms is that it explicitly accounts for “synthetic accessibility” when designing compounds. In other words, it does not simply pursue theoretically possible molecular structures, but aims to generate candidate compounds that are closer to being practically synthesizable.

Core Capabilities and Integrations

Based on the publicly available text, Synopsis focuses on molecular design, especially candidate molecule generation for drug discovery or cheminformatics use cases. It also emphasizes that it can be used together with any other molecular modeling software, making it more of a specialized tool that can be embedded into existing modeling workflows. However, the website does not disclose specific algorithms, AI models, input/output formats, APIs, plugins, or command-line interfaces, nor does it provide benchmarks or case studies. Overall technical transparency is limited.

Pricing, Trial, and Support

The page does not provide any free tier, trial method, licensing model, pricing, or payment information. For support, it only mentions that users can make contact, without specifying service levels, documentation, training, or community resources. The website was last updated in November 2021, so its maintenance activity and product update cadence need further confirmation.

Pros and Cons

Its main strength is its clear positioning: it emphasizes synthetic accessibility in de novo molecular design, which is valuable for reducing molecules that “look feasible” but are difficult to synthesize. Its compatibility with other molecular modeling software also helps it fit into research workflows. The limitations are equally clear: there is too little public information, and key decision-making details are missing, including Chinese-language support, data privacy, deployment options, APIs, output quality validation, and commercial terms.

Who It’s For and Access from China

Synopsis is best suited for researchers, labs, and small R&D teams with backgrounds in molecular modeling, medicinal chemistry, or computational chemistry, especially users who want to introduce synthetic-accessibility constraints at an early design stage. The public text does not mention access from China, so network availability, payment methods, and alternatives would need to be tested directly or confirmed with the maintainer.